World Preclinical Congress Europe

 , 21 December 2017 | Past event

www.worldpreclinicaleurope.com/3D-Cellular-Models/

Cyprio’s HepatoPearls made another appearance in the “3D cellular models; taking screening into a new dimension” session. While the HepatoPearls were being presented to the audience, Cyprio also presented the results of a collaborative project with Sanofi for high throughput drug-drug interaction screenings.

Our very own CEO, Noushin Dianat, was interviewed during the conference:
www.worldpreclinicaleurope.com/interviews/